رسائل ماجيستير
English
2023
Preptin and Irisin as Metabolic Biomarkers in Juvenile Diabetes Mellitus
رحاب فيصل لفتة, زينة عامر حفظي, سيناء بدر محمد
كلية الطب-جامعة بابل · العراق
Type 1diabetes is a chronic autoimmune disorder marked by insulin depletion as a result of pancreatic β-cell damage leading to hyperglycemia. It is commonly occurs in children, adolescent, and young adults. Hyperglycemia eventually develops as the insulin levels decreased, which makes the patients at the risk of oxidative stress and diabetes complications. Due to the absence of a definitive treatment, patients are dependent on everlasting insulin injections. Preptin is a newly discovered peptide hormone derived from pro-insulin-like growth factor-II (IGF-II), synthesized mainly in pancreatic β-cells and coincides with insulin in response to increased blood glucose levels. As preptin has a role in the amplifying of insulin secretion, it might be used as a physiological amplifier for the glucose-mediated insulin secretion. Irisin is a novel exercise-induced myokine secreted from human muscles and mediates the beneficial effects of exercise such as thermoregulation and weight loss. Since there are grateful benefits of exercise induced-irisin, particularly in glucose homeostasis, we suggest that irisin could be used as a therapeutic agonist in patients with type 1 diabetes to increase glucose utilization .C-peptide is a linker chain cleaved from proinsulin in pancreatic β-cells. It was discovered that C-peptide has numerous beneficial effects on various cell types and tissues. C-peptide is used as a biomarker for the function of β-cells because it is secreted in similar quantities with insulin, evade first pass metabolism by the liver, and has a longer half-life than insulin. The present study aims to investigate the levels of irisin and preptin in patients with type 1 diabetes and determine their correlation with C-peptide levels. In addition to determine the correlation of these hormones with glucose levels, to determine the possibility of their usage as a co-therapy with insulin.
Page | II Sample collection was performed from the 1stof September of 2022 until the 13thof February 2023. The practical side of the study was performed in the laboratory of Chemistry and biochemistry department at the College of Medicine/University of Babylon. The present case-control study involved 100 participants with an age range(2-16 years), divided into two groups: 50 apparently healthy control group and 50 patients with type 1 diabetes. The random glucose levels in all participants were estimated by a spectrophotometer, while the levels of preptin, irisin, and C-peptide were measured by Enzyme-Linked Immunosorbent Assay (ELISA) technique. Hemoglobin A1C is measured using an automated analyzer. The study showed a significant decrease in C-peptide levels in the patient group (P≤0.05). Random blood sugar was increased considerably in the patient group (P<0.001). Preptin and irisin levels were significantly increased in the patients group compared with the control group (P<0.05).In addition, this study showed a positive correlation between preptin and irisin (P<0.001). Preptin and irisin also correlated positively with C-peptide (P<0.001). In regression analysis, irisin was a significant predictor for circulating preptin and C-peptide levels. There was also a positive significant correlation between HbA1c and RBS (P=0.028). In conclusion, the positive correlation between preptin and irisin support that there is a relationship between irisin and pancreatic β-cells, and so the development of diabetes mellitus .Irisin is a strong predictor for preptin levels, and thus residual β-cells, therefore it might be used as a predictive marker with C-peptide for T1D. Through the strong association between preptin and C-peptide, preptin could be used as a physiologic amplifier for the second phase insulin secretion